Clinical trial
A Phase 1, Double-Blind, Randomized, Single Dose Escalation Safety Study of…
NCT00456157 · Stryker Biotech, Industry · Completed
Key facts
| NCT number | NCT00456157 |
|---|---|
| Title | A Phase 1, Double-Blind, Randomized, Single Dose Escalation Safety Study of Intra-articular OP-1 in Subjects With Osteoarthritis of the Knee |
| Official title | A Phase 1, Double-Blind, Randomized, Single Dose Escalation Safety Study of Intra-articular Osteogenic Protein-1 OP-1 in Subjects With Osteoarthritis of the Knee |
| Acronym | Knee OA |
| Lead sponsor | Stryker Biotech, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Osteoarthritis of the Knee |
| Intervention type | Drug |
| Interventions | Intra-articular Injection of OP-1 to affected knee |
| Enrollment | 33 |
| Start date | Mar 1, 2007 |
| Completion | Nov 1, 2008 |
| First posted | Apr 4, 2007 |
| Last update posted | Jun 17, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: